These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19915019)

  • 41. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex).
    Stratakis CA
    Ann N Y Acad Sci; 2002 Jun; 968():3-21. PubMed ID: 12119264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary pigmented nodular adrenocortical disease and Cushing's syndrome.
    Horvath A; Stratakis C
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1238-44. PubMed ID: 18209861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.
    Sahut-Barnola I; de Joussineau C; Val P; Lambert-Langlais S; Damon C; Lefrançois-Martinez AM; Pointud JC; Marceau G; Sapin V; Tissier F; Ragazzon B; Bertherat J; Kirschner LS; Stratakis CA; Martinez A
    PLoS Genet; 2010 Jun; 6(6):e1000980. PubMed ID: 20548949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.
    Kirschner LS; Sandrini F; Monbo J; Lin JP; Carney JA; Stratakis CA
    Hum Mol Genet; 2000 Dec; 9(20):3037-46. PubMed ID: 11115848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Novel Missense PRKAR1A Variant Causes Carney Complex.
    Kim B; Jang HN; Chae KS; Shin HS; Kim YH; Kim SJ; Seong MW; Kim JH
    Endocrinol Metab (Seoul); 2022 Oct; 37(5):810-815. PubMed ID: 36193716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PRKAR1A-negative familial Cushing's syndrome: two case reports.
    Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
    J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First Somatic
    Kamilaris CDC; Faucz FR; Andriessen VC; Nilubol N; Lee CR; Ahlman MA; Hannah-Shmouni F; Stratakis CA
    J Endocr Soc; 2021 Apr; 5(4):bvab007. PubMed ID: 33644619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Mutation in the type Iα Regulatory Subunit of Protein Kinase A (PRKAR1A) in a Cushing's Syndrome Patient with Primary Pigmented Nodular Adrenocortical Disease.
    Mineo R; Tamba S; Yamada Y; Okita T; Kawachi Y; Mori R; Kyo M; Saisho K; Kuroda Y; Yamamoto K; Furuya A; Mukai T; Maekawa T; Nakamura Y; Sasano H; Matsuzawa Y
    Intern Med; 2016; 55(17):2433-8. PubMed ID: 27580546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing.
    Salpea P; Horvath A; London E; Faucz FR; Vetro A; Levy I; Gourgari E; Dauber A; Holm IA; Morrison PJ; Keil MF; Lyssikatos C; Smith ED; Sanidad MA; Kelly JC; Dai Z; Mowrey P; Forlino A; Zuffardi O; Stratakis CA
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E183-8. PubMed ID: 24170103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterogeneity of skin manifestations in patients with Carney complex.
    Mateus C; Palangié A; Franck N; Groussin L; Bertagna X; Avril MF; Bertherat J; Dupin N
    J Am Acad Dermatol; 2008 Nov; 59(5):801-10. PubMed ID: 18804312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!
    Stergiopoulos SG; Stratakis CA
    FEBS Lett; 2003 Jul; 546(1):59-64. PubMed ID: 12829237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay.
    Greene EL; Horvath AD; Nesterova M; Giatzakis C; Bossis I; Stratakis CA
    Hum Mutat; 2008 May; 29(5):633-9. PubMed ID: 18241045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications.
    London E; Rothenbuhler A; Lodish M; Gourgari E; Keil M; Lyssikatos C; de la Luz Sierra M; Patronas N; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E303-10. PubMed ID: 24248186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carney Syndrome Presented as a Pathological Spine Fracture in a 35-Year-Old Male.
    Kiriakopoulos A; Linos D
    Am J Case Rep; 2018 Nov; 19():1366-1369. PubMed ID: 30442879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic Variability in a Family with Carney Complex Accompanied by a Novel Mutation Involving PRKAR1A.
    Kubo H; Tsurutani Y; Sugisawa C; Sunouchi T; Hirose R; Saito J
    Tohoku J Exp Med; 2022 Jul; 257(4):337-345. PubMed ID: 35732416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel mutation in
    Ghazi AA; Mandegar MH; Abazari M; Behzadnia N; Sadeghian T; Torbaghan SS; Amirbaigloo A
    Arch Endocrinol Metab; 2021 Nov; 65(3):376-380. PubMed ID: 33939912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
    Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
    Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carney complex due to a novel pathogenic variant in the PRKAR1A gene - a case report.
    Ferreira SH; Costa MM; Rios E; Santos Silva R; Costa C; Castro-Correia C; Fontoura M
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):197-202. PubMed ID: 30699069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel PRKAR1A gene mutation associated with primary pigmented nodular adrenocortical disease.
    Ran H; Ma X; Wang Q; Xie Z; Qin G
    Am J Med Sci; 2014 Aug; 348(2):177-8. PubMed ID: 24978147
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of 3-Dimensional Volumetric Modeling of Adrenal Gland Size in Patients with Primary Pigmented Nodular Adrenocortical Disease.
    Chrysostomou PP; Lodish MB; Turkbey EB; Papadakis GZ; Stratakis CA
    Horm Metab Res; 2016 Apr; 48(4):242-6. PubMed ID: 27065461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.